Clinical data from patients with high-risk Non-Hodgkin's-Lymphoma aged
18-60 years

LHA-ID
7Q0CR2P425-0
Motivation

Improvement of efficacy of chemotherapy for young high-risk patients with high-dose therapy and autologous stem cell transplantation

Description
complete clinical data set for the clinical trial
Study Design

randomised, open-label, multi-centric, prospective phase-III-trial; randomised in 2 arms: conventional chemoimmunotherapy with R-CHOEP-14 and high-dose chemotherapy plus Rituximab with autologous stem cell transplantation

Publication Date
Contact
Marita Ziepert
Version Number
1.0
Sample Size
n=262; R-CHOEP-14 (n=130); R-MegaCHOEP (n=132)